Trademark Information

Application ID
Status
Date of Application
21 February 2017
Classes
10
Proprietor
221, Damji Shamji Industrial Complex, 9 L.B.S. Marg, Kurla (W), Mumbai 400 070.
Agent
Bharat Bapusaheb Thite[32330]
Flat N.28, Samita Housing Complex, 74/1, B+2, Katraj, Pune 411046.
Type
Device
State
Maharashtra
Country
Filing Mode
e-Filing
IP Office
MUMBAI
Used Since
01 January 2017
Valid / Upto
21 February 2027
Description
[Class : 10] Surgical, Medical, Dental And Veterinary Apparatus And Instruments; Artificial Limbs, Eyes And Teeth; Orthopaedic Articles; Suture Materials; Therapeutic And Assistive Devices Adapted For The Disabled

Image (DEVICE)

Ndovasive: Precision That Empowers Device mark 3489720 Trademark

Documents

Examination Report

Uploaded Documents

1 Other Documents 21 Feb 2017
2 TM-1 21 Feb 2017
3 Power of Attorney 21 Feb 2017
4 TM-M(CORRECTION OF CLERICAL ERROR OR FOR AMENDMENT U/R 37) 13 Apr 2017
5 Journal Copy 07 Aug 2017
6 Certificate 31 Dec 2017
7 TM-M(CORRECTION OF CLERICAL ERROR OR FOR AMENDMENT U/R 37) 16 Feb 2023

Correspondence and Notices

1 Application(3489720) Keep Pending 4616825 2063527 08 Mar 2017

Frequently Asked Questions

When was the trademark applied?

The application for Ndovasive: precision that empowers was made on 21 February 2017.

Who is the applicant for Ndovasive: precision that empowers?

The trademark applicant for Ndovasive: precision that empowers is BIORAD MEDISYS.

In what class is the trademark applied to?

Ndovasive: precision that empowers is applied in class(es) 10.

What is the status of the trademark application?

Application for Ndovasive: precision that empowers is on Registered stage.

What is the application ID of the trademark?

Application Id allotted to Ndovasive: precision that empowers is 3489720.

Who is the trademark agent or attorney?

Trademark agent or attorney for the application is Bharat Bapusaheb Thite.

What is the type of trademark application?

Ndovasive: precision that empowers filed with the Intellectual property office as a DEVICE.